MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Myriad Genetics ROA Ratio 2011-2026 | MYGN
Annual ROA Ratio Myriad Genetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51.8 | -12.36 | -22.94 | -9.34 | -2.06 | -3.78 | 0.29 | 11.17 | 1.78 | 14.23 | 10.47 | 21.39 | 18.3 | 16.24 | 16.49 | 25.65 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.65 | -51.8 | 2.11 |
Quarterly ROA Ratio Myriad Genetics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -57.63 | -54.61 | -54.23 | -7.78 | -7.77 | -13.1 | -20.84 | -22.13 | -19.79 | -22.69 | -18.99 | -7.37 | -2.69 | -3.03 | -0.14 | -3.09 | -1.46 | -4.13 | -7.04 | -10.6 | -8.72 | -6.57 | -6.02 | -2.65 | -2.9 | -2.2 | -1.52 | -0.76 | 0.49 | 2.84 | 9.09 | 11.53 | 18.21 | 16.17 | 9.7 | 7.72 | 0.96 | 4.73 | 8.64 | 11.92 | 15.53 | 14.35 | 12.47 | 11.44 | 9.9 | 13.49 | 18.61 | 21.96 | 26.92 | 25.14 | 22.33 | 21.14 | 18.6 | 18.0 | 17.82 | 17.38 | 17.12 | 4.1 | 4.63 | 4.11 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26.92 | -57.63 | 0.78 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Agilent Technologies
A
|
11.3 | $ 111.7 | -1.38 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 19.13 | 1.32 % | $ 555 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
22.84 | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 150.85 | -5.2 % | $ 7.48 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 25.23 | -1.06 % | $ 23.9 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
-24.32 | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-83.65 | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.57 | -1.59 % | $ 205 M | Irlanda |
 |
Celcuity
CELC
|
-37.95 | $ 137.68 | 2.2 % | $ 6.44 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 329.22 | -1.2 % | $ 19.6 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 186.61 | -0.71 % | $ 20.7 B | USA |